| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF20 ZNF48 ZFP41 NSD1 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 2.57e-06 | 1459 | 58 | 16 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 8.42e-06 | 1412 | 58 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | integrin binding | 1.15e-05 | 175 | 58 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.73e-05 | 188 | 58 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 3.68e-04 | 10 | 58 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.39e-04 | 51 | 58 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | activin binding | 5.37e-04 | 12 | 58 | 2 | GO:0048185 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.25e-03 | 73 | 58 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.69e-03 | 599 | 58 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | collagen binding | 1.69e-03 | 81 | 58 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.94e-03 | 85 | 58 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.06e-03 | 1189 | 58 | 10 | GO:0046914 | |
| GeneOntologyMolecularFunction | opsonin binding | 2.38e-03 | 25 | 58 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | Notch binding | 2.78e-03 | 27 | 58 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.78e-03 | 27 | 58 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF48 NSD1 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF251 ZNF786 | 2.86e-03 | 1244 | 58 | 10 | GO:0000978 |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 3.20e-03 | 29 | 58 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF48 NSD1 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF251 ZNF786 | 3.34e-03 | 1271 | 58 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | complement binding | 3.89e-03 | 32 | 58 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.04e-03 | 891 | 58 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | laminin binding | 4.38e-03 | 34 | 58 | 2 | GO:0043236 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 9.67e-07 | 270 | 59 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.45e-06 | 124 | 59 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of activin receptor signaling pathway | 2.04e-06 | 32 | 59 | 4 | GO:0032925 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.08e-05 | 410 | 59 | 8 | GO:0031589 | |
| GeneOntologyBiologicalProcess | activin receptor signaling pathway | 2.61e-05 | 60 | 59 | 4 | GO:0032924 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 2.85e-05 | 21 | 59 | 3 | GO:0032926 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.34e-04 | 91 | 59 | 4 | GO:0033627 | |
| GeneOntologyCellularComponent | basement membrane | 2.43e-05 | 122 | 59 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.64e-05 | 656 | 59 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.84e-05 | 658 | 59 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | integrin complex | 9.99e-05 | 32 | 59 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.17e-04 | 6 | 59 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.17e-04 | 8 | 59 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.17e-04 | 8 | 59 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.17e-04 | 8 | 59 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | sperm head plasma membrane | 4.24e-04 | 11 | 59 | 2 | GO:1990913 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.21e-04 | 59 | 59 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.06e-04 | 530 | 59 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.59e-03 | 21 | 59 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | sperm plasma membrane | 1.74e-03 | 22 | 59 | 2 | GO:0097524 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.43e-03 | 332 | 59 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | sperm head | 3.24e-03 | 30 | 59 | 2 | GO:0061827 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.63e-03 | 109 | 59 | 3 | GO:0005796 | |
| HumanPheno | Glomerular basement membrane lamellation | 3.14e-05 | 3 | 17 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 3.14e-05 | 3 | 17 | 2 | HP:0011501 | |
| HumanPheno | Glomerular deposits | 3.40e-05 | 20 | 17 | 3 | HP:0030949 | |
| Domain | EGF_1 | SNED1 CRELD1 LAMB4 ITGBL1 NELL2 FN1 ADAM21 ADAM9 NTNG1 ADAM30 ITGB2 AGRN ITGB5 SVEP1 MEGF10 | 1.25e-15 | 255 | 58 | 15 | PS00022 |
| Domain | EGF-like_CS | SNED1 CRELD1 LAMB4 NELL2 FN1 ADAM21 ADAM9 NTNG1 ADAM30 ITGB2 AGRN ITGB5 SVEP1 MEGF10 | 4.48e-14 | 261 | 58 | 14 | IPR013032 |
| Domain | EGF_2 | SNED1 CRELD1 LAMB4 ITGBL1 NELL2 ADAM21 ADAM9 NTNG1 ADAM30 ITGB2 AGRN ITGB5 SVEP1 MEGF10 | 5.53e-14 | 265 | 58 | 14 | PS01186 |
| Domain | EGF-like_dom | PCSK5 SNED1 CRELD1 ITGBL1 NELL2 ADAM21 ADAM9 NTNG1 ADAM30 AGRN SVEP1 MEGF10 | 1.25e-11 | 249 | 58 | 12 | IPR000742 |
| Domain | zf-C2H2 | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 ZNF687 | 1.88e-11 | 693 | 58 | 17 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 ZNF687 | 1.92e-11 | 694 | 58 | 17 | IPR013087 |
| Domain | KRAB | ZNF20 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 5.50e-11 | 358 | 58 | 13 | PS50805 |
| Domain | KRAB | ZNF20 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 5.50e-11 | 358 | 58 | 13 | PF01352 |
| Domain | KRAB | ZNF20 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 8.01e-11 | 369 | 58 | 13 | SM00349 |
| Domain | KRAB | ZNF20 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 8.28e-11 | 370 | 58 | 13 | IPR001909 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 ZNF687 | 1.08e-10 | 775 | 58 | 17 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 ZNF687 | 1.12e-10 | 777 | 58 | 17 | PS00028 |
| Domain | EGF | PCSK5 SNED1 CRELD1 ITGBL1 NELL2 ADAM9 NTNG1 AGRN ITGB5 SVEP1 MEGF10 | 1.34e-10 | 235 | 58 | 11 | SM00181 |
| Domain | - | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 1.51e-10 | 679 | 58 | 16 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 ZNF687 | 1.63e-10 | 796 | 58 | 17 | IPR015880 |
| Domain | Znf_C2H2 | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 ZNF687 | 1.94e-10 | 805 | 58 | 17 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 ZNF687 | 2.05e-10 | 808 | 58 | 17 | SM00355 |
| Domain | EGF_extracell | 6.51e-10 | 60 | 58 | 7 | IPR013111 | |
| Domain | EGF_2 | 6.51e-10 | 60 | 58 | 7 | PF07974 | |
| Domain | EGF_3 | SNED1 CRELD1 NELL2 ADAM21 ADAM9 NTNG1 ADAM30 AGRN SVEP1 MEGF10 | 2.53e-09 | 235 | 58 | 10 | PS50026 |
| Domain | Fol_N | 2.72e-08 | 11 | 58 | 4 | IPR003645 | |
| Domain | FOLN | 2.72e-08 | 11 | 58 | 4 | SM00274 | |
| Domain | zf-C2H2_6 | ZNF20 ZNF48 ZNF814 ZNF479 ZNF224 ZNF324B ZNF442 ZNF251 ZNF443 ZNF169 | 4.00e-08 | 314 | 58 | 10 | PF13912 |
| Domain | Laminin_EGF | 7.32e-08 | 35 | 58 | 5 | PF00053 | |
| Domain | Laminin_EGF | 1.12e-07 | 38 | 58 | 5 | IPR002049 | |
| Domain | Integrin_bsu | 2.36e-06 | 9 | 58 | 3 | IPR015812 | |
| Domain | INTEGRIN_BETA | 2.36e-06 | 9 | 58 | 3 | PS00243 | |
| Domain | EGF_Lam | 4.08e-06 | 35 | 58 | 4 | SM00180 | |
| Domain | Disintegrin_CS | 1.55e-05 | 16 | 58 | 3 | IPR018358 | |
| Domain | ADAM_CR | 2.24e-05 | 18 | 58 | 3 | PF08516 | |
| Domain | - | 3.12e-05 | 20 | 58 | 3 | 4.10.70.10 | |
| Domain | Disintegrin | 3.63e-05 | 21 | 58 | 3 | PF00200 | |
| Domain | DISIN | 3.63e-05 | 21 | 58 | 3 | SM00050 | |
| Domain | EGF_CA | 3.80e-05 | 122 | 58 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.11e-05 | 124 | 58 | 5 | IPR001881 | |
| Domain | Kazal_1 | 4.20e-05 | 22 | 58 | 3 | PF00050 | |
| Domain | ACR | 7.88e-05 | 27 | 58 | 3 | SM00608 | |
| Domain | ADAM_Cys-rich | 7.88e-05 | 27 | 58 | 3 | IPR006586 | |
| Domain | hEGF | 8.81e-05 | 28 | 58 | 3 | PF12661 | |
| Domain | FOLN | 9.42e-05 | 5 | 58 | 2 | PF09289 | |
| Domain | Follistatin/Osteonectin_EGF | 9.42e-05 | 5 | 58 | 2 | IPR015369 | |
| Domain | EGF_LAM_2 | 1.09e-04 | 30 | 58 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.09e-04 | 30 | 58 | 3 | PS01248 | |
| Domain | C4 | 1.41e-04 | 6 | 58 | 2 | SM00111 | |
| Domain | - | 1.41e-04 | 6 | 58 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.41e-04 | 6 | 58 | 2 | IPR001442 | |
| Domain | Integrin_bsu_cyt_dom | 1.41e-04 | 6 | 58 | 2 | IPR014836 | |
| Domain | C4 | 1.41e-04 | 6 | 58 | 2 | PF01413 | |
| Domain | HELP | 1.41e-04 | 6 | 58 | 2 | PF03451 | |
| Domain | HELP | 1.41e-04 | 6 | 58 | 2 | IPR005108 | |
| Domain | NC1_IV | 1.41e-04 | 6 | 58 | 2 | PS51403 | |
| Domain | Integrin_b_cyt | 1.41e-04 | 6 | 58 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 1.41e-04 | 6 | 58 | 2 | PF08725 | |
| Domain | Haem_d1 | 1.41e-04 | 6 | 58 | 2 | IPR011048 | |
| Domain | Kazal_2 | 1.89e-04 | 36 | 58 | 3 | PF07648 | |
| Domain | Integrin_bsu_tail | 1.97e-04 | 7 | 58 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 1.97e-04 | 7 | 58 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 1.97e-04 | 7 | 58 | 2 | PF07965 | |
| Domain | EGF_Ca-bd_CS | 2.34e-04 | 97 | 58 | 4 | IPR018097 | |
| Domain | Peptidase_M12B_N | 2.40e-04 | 39 | 58 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.40e-04 | 39 | 58 | 3 | PF01562 | |
| Domain | EGF_CA | 2.53e-04 | 99 | 58 | 4 | PS01187 | |
| Domain | DISINTEGRIN_1 | 2.59e-04 | 40 | 58 | 3 | PS00427 | |
| Domain | Reprolysin | 2.59e-04 | 40 | 58 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 2.59e-04 | 40 | 58 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.59e-04 | 40 | 58 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 2.59e-04 | 40 | 58 | 3 | IPR001590 | |
| Domain | Integrin_beta | 2.62e-04 | 8 | 58 | 2 | PF00362 | |
| Domain | INB | 2.62e-04 | 8 | 58 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 2.62e-04 | 8 | 58 | 2 | IPR002369 | |
| Domain | ASX_HYDROXYL | 2.63e-04 | 100 | 58 | 4 | PS00010 | |
| Domain | Disintegrin_dom | 2.79e-04 | 41 | 58 | 3 | IPR001762 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.29e-04 | 106 | 58 | 4 | IPR000152 | |
| Domain | Integin_beta_N | 3.36e-04 | 9 | 58 | 2 | IPR033760 | |
| Domain | TB | 3.36e-04 | 9 | 58 | 2 | PS51364 | |
| Domain | TB_dom | 3.36e-04 | 9 | 58 | 2 | IPR017878 | |
| Domain | PSI_integrin | 3.36e-04 | 9 | 58 | 2 | PF17205 | |
| Domain | KAZAL | 3.92e-04 | 46 | 58 | 3 | SM00280 | |
| Domain | KAZAL_2 | 5.02e-04 | 50 | 58 | 3 | PS51465 | |
| Domain | Znf_CXXC | 5.12e-04 | 11 | 58 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 5.12e-04 | 11 | 58 | 2 | PS51058 | |
| Domain | zf-CXXC | 5.12e-04 | 11 | 58 | 2 | PF02008 | |
| Domain | Kazal_dom | 5.32e-04 | 51 | 58 | 3 | IPR002350 | |
| Domain | Quinoprot_gluc/sorb_DH | 6.13e-04 | 12 | 58 | 2 | IPR011041 | |
| Domain | EGF | 6.32e-04 | 126 | 58 | 4 | PF00008 | |
| Domain | IBR | 8.42e-04 | 14 | 58 | 2 | SM00647 | |
| Domain | IBR | 8.42e-04 | 14 | 58 | 2 | PF01485 | |
| Domain | IBR_dom | 9.70e-04 | 15 | 58 | 2 | IPR002867 | |
| Domain | Post-SET_dom | 1.11e-03 | 16 | 58 | 2 | IPR003616 | |
| Domain | PostSET | 1.11e-03 | 16 | 58 | 2 | SM00508 | |
| Domain | Laminin_N | 1.11e-03 | 16 | 58 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 1.11e-03 | 16 | 58 | 2 | PS51117 | |
| Domain | Laminin_N | 1.11e-03 | 16 | 58 | 2 | PF00055 | |
| Domain | POST_SET | 1.11e-03 | 16 | 58 | 2 | PS50868 | |
| Domain | LamNT | 1.11e-03 | 16 | 58 | 2 | SM00136 | |
| Domain | Growth_fac_rcpt_ | 1.40e-03 | 156 | 58 | 4 | IPR009030 | |
| Domain | Furin_repeat | 1.40e-03 | 18 | 58 | 2 | IPR006212 | |
| Domain | FU | 1.40e-03 | 18 | 58 | 2 | SM00261 | |
| Domain | KAZAL_1 | 1.40e-03 | 18 | 58 | 2 | PS00282 | |
| Domain | - | 1.58e-03 | 74 | 58 | 3 | 3.40.50.410 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.10e-07 | 85 | 46 | 6 | M16441 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.30e-06 | 59 | 46 | 5 | M27218 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.60e-06 | 76 | 46 | 5 | M27219 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.95e-06 | 300 | 46 | 8 | M610 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.54e-06 | 84 | 46 | 5 | M7098 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ITGBL1 ZNF20 ZNF696 KMT2A ZNF479 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF443 ZNF786 ZNF169 SMAD7 | 8.69e-05 | 1387 | 46 | 14 | M734 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.89e-05 | 140 | 46 | 5 | M587 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.07e-04 | 76 | 46 | 4 | MM14867 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.51e-04 | 32 | 46 | 3 | MM14924 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.80e-04 | 258 | 46 | 6 | MM14572 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.34e-04 | 37 | 46 | 3 | M27134 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.65e-04 | 96 | 46 | 4 | M39834 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 3.41e-04 | 42 | 46 | 3 | M174 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.41e-04 | 42 | 46 | 3 | M7169 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 3.66e-04 | 43 | 46 | 3 | M53 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.92e-04 | 44 | 46 | 3 | M26969 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 4.61e-04 | 10 | 46 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 4.61e-04 | 10 | 46 | 2 | MM1560 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.09e-04 | 114 | 46 | 4 | MM14571 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.62e-04 | 11 | 46 | 2 | M15422 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 5.62e-04 | 11 | 46 | 2 | M27184 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 5.62e-04 | 11 | 46 | 2 | MM14897 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 6.73e-04 | 12 | 46 | 2 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.94e-04 | 13 | 46 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.94e-04 | 13 | 46 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 9.25e-04 | 14 | 46 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 9.25e-04 | 14 | 46 | 2 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.06e-03 | 15 | 46 | 2 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.06e-03 | 15 | 46 | 2 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 1.06e-03 | 15 | 46 | 2 | MM14593 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.13e-03 | 63 | 46 | 3 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.18e-03 | 64 | 46 | 3 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.29e-03 | 66 | 46 | 3 | M18 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.37e-03 | 17 | 46 | 2 | M212 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 1.37e-03 | 17 | 46 | 2 | M26965 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.54e-03 | 18 | 46 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.54e-03 | 18 | 46 | 2 | MM14882 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.66e-03 | 72 | 46 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.72e-03 | 73 | 46 | 3 | MM15906 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.79e-03 | 74 | 46 | 3 | M160 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.84e-03 | 161 | 46 | 4 | M27871 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.84e-03 | 161 | 46 | 4 | M39770 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.91e-03 | 20 | 46 | 2 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.91e-03 | 20 | 46 | 2 | MM15061 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.52e-03 | 23 | 46 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.52e-03 | 23 | 46 | 2 | MM1427 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 2.52e-03 | 23 | 46 | 2 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 2.52e-03 | 23 | 46 | 2 | M47720 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.58e-03 | 84 | 46 | 3 | M3228 | |
| Pathway | WP_FOCAL_ADHESION | 3.17e-03 | 187 | 46 | 4 | MM15913 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 3.22e-03 | 26 | 46 | 2 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 3.22e-03 | 26 | 46 | 2 | M47719 | |
| Pathway | REACTOME_FERTILIZATION | 3.22e-03 | 26 | 46 | 2 | M26922 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.47e-03 | 27 | 46 | 2 | M27217 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 3.73e-03 | 28 | 46 | 2 | M47655 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.96e-03 | 199 | 46 | 4 | M7253 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.28e-03 | 30 | 46 | 2 | M27216 | |
| Pathway | REACTOME_REPRODUCTION | 4.28e-03 | 30 | 46 | 2 | MM17211 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 4.28e-03 | 30 | 46 | 2 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 4.28e-03 | 30 | 46 | 2 | M47718 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.77e-03 | 339 | 46 | 5 | M39736 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.85e-03 | 32 | 46 | 2 | MM14854 | |
| Pathway | WP_BURN_WOUND_HEALING | 5.93e-03 | 113 | 46 | 3 | M42571 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.68e-03 | 118 | 46 | 3 | MM15588 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.80e-03 | 38 | 46 | 2 | MM14969 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.15e-03 | 39 | 46 | 2 | MM14601 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 16336961 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.11e-08 | 248 | 60 | 8 | 24006456 | |
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.70e-07 | 7 | 60 | 3 | 10716744 | |
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 3997552 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 1383086 | ||
| Pubmed | 5.81e-07 | 10 | 60 | 3 | 9415455 | ||
| Pubmed | 5.95e-07 | 175 | 60 | 6 | 28071719 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 7.97e-07 | 11 | 60 | 3 | 7500359 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.06e-06 | 12 | 60 | 3 | 12180907 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 1.38e-06 | 13 | 60 | 3 | 9833687 | |
| Pubmed | Deletion of astroglial connexins weakens the blood-brain barrier. | 1.75e-06 | 14 | 60 | 3 | 22472609 | |
| Pubmed | 1.94e-06 | 118 | 60 | 5 | 21078624 | ||
| Pubmed | 2.19e-06 | 15 | 60 | 3 | 23011393 | ||
| Pubmed | Targeted Disruption of Mouse Dip2B Leads to Abnormal Lung Development and Prenatal Lethality. | 2.20e-06 | 53 | 60 | 4 | 33153107 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 COL4A5 ZNF48 RHBDF2 NSD1 CLDN3 ZNF324B AGRN ITGB5 ZNF687 SMAD7 | 2.61e-06 | 1105 | 60 | 11 | 35748872 |
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 17881772 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11739004 | ||
| Pubmed | Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. | 2.93e-06 | 2 | 60 | 2 | 21546932 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 37739334 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9195222 | ||
| Pubmed | Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis. | 2.93e-06 | 2 | 60 | 2 | 17296189 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15451564 | ||
| Pubmed | Insights into extracellular matrix functions from mutant mouse models. | 2.93e-06 | 2 | 60 | 2 | 11082275 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23533219 | ||
| Pubmed | Differential expression of follistatin and FLRG in human breast proliferative disorders. | 2.93e-06 | 2 | 60 | 2 | 19740438 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16150905 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 28632965 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16627583 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31892712 | ||
| Pubmed | 3.26e-06 | 17 | 60 | 3 | 18082680 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.76e-06 | 135 | 60 | 5 | 28675934 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 8.77e-06 | 3 | 60 | 2 | 27576055 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 16373656 | ||
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 8.77e-06 | 3 | 60 | 2 | 15954103 | |
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 8.77e-06 | 3 | 60 | 2 | 27859054 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17396119 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 24522496 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 7962065 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 8.77e-06 | 3 | 60 | 2 | 28542346 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 28704582 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 18930919 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 8.77e-06 | 3 | 60 | 2 | 30647093 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11162558 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 38978054 | ||
| Pubmed | A scaffold for signaling of Tim-4-mediated efferocytosis is formed by fibronectin. | 8.77e-06 | 3 | 60 | 2 | 30451988 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 20301386 | ||
| Pubmed | Deregulation of the activin/follistatin system in hepatocarcinogenesis. | 8.77e-06 | 3 | 60 | 2 | 16935389 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 36130833 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 14507670 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 8.77e-06 | 3 | 60 | 2 | 38433557 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11948405 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 25575550 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 21829661 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 24033287 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 14633121 | ||
| Pubmed | 1.06e-05 | 167 | 60 | 5 | 22159717 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.09e-05 | 79 | 60 | 4 | 18757743 | |
| Pubmed | 1.73e-05 | 29 | 60 | 3 | 22613833 | ||
| Pubmed | Strength training with blood flow restriction diminishes myostatin gene expression. | 1.75e-05 | 4 | 60 | 2 | 21900845 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 17878677 | ||
| Pubmed | Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family. | 1.75e-05 | 4 | 60 | 2 | 12531697 | |
| Pubmed | TGF-beta3-null mutation does not abrogate fetal lung maturation in vivo by glucocorticoids. | 1.75e-05 | 4 | 60 | 2 | 10600892 | |
| Pubmed | FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation. | 1.75e-05 | 4 | 60 | 2 | 15574124 | |
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 2.12e-05 | 31 | 60 | 3 | 11431694 | |
| Pubmed | 2.34e-05 | 32 | 60 | 3 | 23154389 | ||
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 2.57e-05 | 33 | 60 | 3 | 26864203 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 9421166 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 22395277 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 14499643 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 12697670 | ||
| Pubmed | FLRG, member of the follistatin family, a new player in hematopoiesis. | 2.92e-05 | 5 | 60 | 2 | 15451575 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 23763354 | ||
| Pubmed | Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. | 2.92e-05 | 5 | 60 | 2 | 9442085 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 19701759 | ||
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 2.92e-05 | 5 | 60 | 2 | 12592609 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 4.37e-05 | 6 | 60 | 2 | 9506531 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 7495302 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 17548654 | ||
| Pubmed | Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-κB Signaling. | 4.37e-05 | 6 | 60 | 2 | 26600301 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 4.37e-05 | 6 | 60 | 2 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 4.37e-05 | 6 | 60 | 2 | 6811420 | |
| Pubmed | Vector-capping: a simple method for preparing a high-quality full-length cDNA library. | 4.37e-05 | 6 | 60 | 2 | 16106752 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 4.37e-05 | 6 | 60 | 2 | 6389236 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 4.37e-05 | 6 | 60 | 2 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 4.37e-05 | 6 | 60 | 2 | 9673377 | |
| Pubmed | HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. | 4.37e-05 | 6 | 60 | 2 | 8757599 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 11732842 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 1694173 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 4.37e-05 | 6 | 60 | 2 | 19275937 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 6988303 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 4.99e-05 | 560 | 60 | 7 | 21653829 | |
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 10639489 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 6.11e-05 | 7 | 60 | 2 | 8006028 | |
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 20810712 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 10416788 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 21778429 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 23273220 | ||
| Interaction | FBLN2 interactions | 1.29e-06 | 66 | 58 | 5 | int:FBLN2 | |
| Interaction | LTBP4 interactions | 1.40e-06 | 67 | 58 | 5 | int:LTBP4 | |
| Interaction | LTBP1 interactions | 6.72e-06 | 92 | 58 | 5 | int:LTBP1 | |
| Interaction | DCN interactions | 7.01e-06 | 43 | 58 | 4 | int:DCN | |
| Interaction | KRTAP10-7 interactions | 2.04e-05 | 293 | 58 | 7 | int:KRTAP10-7 | |
| Interaction | LYPD1 interactions | 2.33e-05 | 58 | 58 | 4 | int:LYPD1 | |
| Interaction | NOTCH2 interactions | 2.70e-05 | 423 | 58 | 8 | int:NOTCH2 | |
| Interaction | FBN2 interactions | 3.67e-05 | 65 | 58 | 4 | int:FBN2 | |
| Interaction | ADAM20 interactions | 4.87e-05 | 4 | 58 | 2 | int:ADAM20 | |
| Interaction | ITGB5 interactions | 6.47e-05 | 147 | 58 | 5 | int:ITGB5 | |
| Interaction | LRP4 interactions | 8.71e-05 | 81 | 58 | 4 | int:LRP4 | |
| Interaction | LTBP2 interactions | 1.05e-04 | 85 | 58 | 4 | int:LTBP2 | |
| Interaction | LRP1B interactions | 1.05e-04 | 85 | 58 | 4 | int:LRP1B | |
| Interaction | FST interactions | 1.06e-04 | 32 | 58 | 3 | int:FST | |
| Interaction | LTBP3 interactions | 1.39e-04 | 35 | 58 | 3 | int:LTBP3 | |
| Interaction | FBXO2 interactions | 1.71e-04 | 411 | 58 | 7 | int:FBXO2 | |
| Interaction | ATN1 interactions | 2.01e-04 | 187 | 58 | 5 | int:ATN1 | |
| Interaction | TOP3B interactions | PCSK5 COL4A5 ZNF48 RHBDF2 TRIM56 NSD1 CLDN3 ZNF324B DNAJA1 AGRN ITGB5 ZNF687 SMAD7 | 2.23e-04 | 1470 | 58 | 13 | int:TOP3B |
| Cytoband | 8q24.3 | 1.53e-05 | 113 | 60 | 4 | 8q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.22e-03 | 355 | 60 | 4 | chr8q24 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF20 ZNF48 ZFP41 ZNF696 ZNF814 ZNF479 ZKSCAN2 ZNF528 ZNF224 ZNF324B ZNF285 ZNF442 ZNF251 ZNF443 ZNF786 ZNF169 | 4.52e-11 | 718 | 50 | 16 | 28 |
| GeneFamily | CD molecules|Integrin beta subunits | 1.65e-06 | 9 | 50 | 3 | 1159 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.56e-05 | 27 | 50 | 3 | 47 | |
| GeneFamily | Zinc fingers CXXC-type | 4.86e-04 | 12 | 50 | 2 | 136 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.97e-03 | 34 | 50 | 2 | 487 | |
| GeneFamily | Collagens | 7.18e-03 | 46 | 50 | 2 | 490 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.09e-02 | 57 | 50 | 2 | 1179 | |
| Coexpression | NABA_MATRISOME | PCSK5 COL4A4 COL4A5 SNED1 CRELD1 NELL2 FN1 FSTL3 ADAM21 ADAM9 NTNG1 ADAM30 ELN FST AGRN SVEP1 MEGF10 EGFEM1P | 5.86e-12 | 1008 | 60 | 18 | MM17056 |
| Coexpression | NABA_MATRISOME | PCSK5 COL4A4 COL4A5 SNED1 CRELD1 LAMB4 NELL2 FN1 FSTL3 ADAM21 ADAM9 NTNG1 ADAM30 ELN FST AGRN SVEP1 MEGF10 | 7.85e-12 | 1026 | 60 | 18 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 COL4A5 SNED1 CRELD1 NELL2 FN1 NTNG1 ELN AGRN SVEP1 EGFEM1P | 2.48e-11 | 270 | 60 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 COL4A5 SNED1 CRELD1 LAMB4 NELL2 FN1 NTNG1 ELN AGRN SVEP1 | 3.02e-11 | 275 | 60 | 11 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.15e-10 | 191 | 60 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.47e-10 | 196 | 60 | 9 | M3008 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.28e-08 | 40 | 60 | 5 | M5887 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 7.20e-06 | 54 | 60 | 4 | M4737 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.95e-05 | 23 | 60 | 3 | M48001 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 3.99e-05 | 29 | 60 | 3 | M47987 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 3.99e-05 | 29 | 60 | 3 | MM17055 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 4.43e-05 | 30 | 60 | 3 | M1550 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 4.90e-05 | 31 | 60 | 3 | MM665 | |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 9.34e-05 | 199 | 60 | 5 | M8477 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP | 9.56e-05 | 200 | 60 | 5 | M3962 | |
| Coexpression | BEIER_GLIOMA_STEM_CELL_UP | 1.06e-04 | 40 | 60 | 3 | M9126 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 1.14e-04 | 41 | 60 | 3 | M47988 | |
| Coexpression | BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN | 1.57e-04 | 118 | 60 | 4 | M34005 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-10 | 192 | 60 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.20e-09 | 195 | 60 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.63e-07 | 181 | 60 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.98e-07 | 187 | 60 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.45e-07 | 194 | 60 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 2.45e-07 | 194 | 60 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-07 | 195 | 60 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-07 | 198 | 60 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.77e-07 | 198 | 60 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.85e-07 | 199 | 60 | 6 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.85e-07 | 199 | 60 | 6 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.85e-07 | 199 | 60 | 6 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-07 | 200 | 60 | 6 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.93e-07 | 200 | 60 | 6 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-07 | 200 | 60 | 6 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-07 | 200 | 60 | 6 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-07 | 200 | 60 | 6 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-07 | 200 | 60 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.93e-07 | 200 | 60 | 6 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 176 | 60 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 176 | 60 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.43e-06 | 180 | 60 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-06 | 181 | 60 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-06 | 181 | 60 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-06 | 181 | 60 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-06 | 185 | 60 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-06 | 185 | 60 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.33e-06 | 187 | 60 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.76e-06 | 190 | 60 | 5 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.76e-06 | 190 | 60 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-06 | 191 | 60 | 5 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-06 | 191 | 60 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-06 | 191 | 60 | 5 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-06 | 192 | 60 | 5 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-06 | 192 | 60 | 5 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.06e-06 | 192 | 60 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.22e-06 | 193 | 60 | 5 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-06 | 193 | 60 | 5 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.22e-06 | 193 | 60 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.22e-06 | 193 | 60 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.22e-06 | 193 | 60 | 5 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.38e-06 | 194 | 60 | 5 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 6.38e-06 | 194 | 60 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.38e-06 | 194 | 60 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-06 | 194 | 60 | 5 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 6.38e-06 | 194 | 60 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 6.54e-06 | 195 | 60 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.54e-06 | 195 | 60 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 6.70e-06 | 196 | 60 | 5 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.70e-06 | 196 | 60 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.70e-06 | 196 | 60 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 197 | 60 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-06 | 197 | 60 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-06 | 197 | 60 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 197 | 60 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-06 | 197 | 60 | 5 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.87e-06 | 197 | 60 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 197 | 60 | 5 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 7.04e-06 | 198 | 60 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.04e-06 | 198 | 60 | 5 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.04e-06 | 198 | 60 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.04e-06 | 198 | 60 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.22e-06 | 199 | 60 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.22e-06 | 199 | 60 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.22e-06 | 199 | 60 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.22e-06 | 199 | 60 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.22e-06 | 199 | 60 | 5 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.22e-06 | 199 | 60 | 5 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-06 | 199 | 60 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-06 | 199 | 60 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.39e-06 | 200 | 60 | 5 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.39e-06 | 200 | 60 | 5 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.39e-06 | 200 | 60 | 5 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-06 | 200 | 60 | 5 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-06 | 200 | 60 | 5 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.39e-06 | 200 | 60 | 5 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.39e-06 | 200 | 60 | 5 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.39e-06 | 200 | 60 | 5 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.39e-06 | 200 | 60 | 5 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.39e-06 | 200 | 60 | 5 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.39e-06 | 200 | 60 | 5 | 869d45b71efd395d050873db5fee2ed0443d5e6f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | f74b9b0e27afedd589e828d30194e8417029817a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | 9dd2eb70c1cc146935f5aff27373dfc65cb8c098 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.39e-06 | 200 | 60 | 5 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.39e-06 | 200 | 60 | 5 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.39e-06 | 200 | 60 | 5 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-06 | 200 | 60 | 5 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.39e-06 | 200 | 60 | 5 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.43e-05 | 160 | 60 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| Computational | Adhesion molecules. | 4.55e-06 | 141 | 34 | 6 | MODULE_122 | |
| Computational | Breast cancer expression clusters. | 2.44e-04 | 98 | 34 | 4 | MODULE_480 | |
| Computational | Genes in the cancer module 427. | 4.65e-04 | 116 | 34 | 4 | MODULE_427 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.12e-04 | 50 | 34 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.12e-04 | 50 | 34 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8 | |
| Computational | Genes in the cancer module 412. | 7.41e-04 | 13 | 34 | 2 | MODULE_412 | |
| Computational | Genes in the cancer module 256. | 9.18e-04 | 61 | 34 | 3 | MODULE_256 | |
| Computational | Genes in the cancer module 275. | 1.13e-03 | 16 | 34 | 2 | MODULE_275 | |
| Disease | Alport syndrome | 1.14e-05 | 3 | 58 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.14e-05 | 3 | 58 | 2 | cv:CN076135 | |
| Disease | unipolar depression, depressive symptom measurement | 1.81e-05 | 26 | 58 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | Hematuria, Benign Familial | 2.27e-05 | 4 | 58 | 2 | C0241908 | |
| Disease | Alport Syndrome | 2.27e-05 | 4 | 58 | 2 | C1567741 | |
| Disease | Weaver syndrome | 3.78e-05 | 5 | 58 | 2 | C0265210 | |
| Disease | Alport Syndrome, X-Linked | 3.78e-05 | 5 | 58 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 3.78e-05 | 5 | 58 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 3.78e-05 | 5 | 58 | 2 | C1567744 | |
| Disease | myopathy (implicated_via_orthology) | 1.17e-04 | 48 | 58 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 2.47e-04 | 12 | 58 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | heel bone mineral density, urate measurement | 4.58e-04 | 182 | 58 | 4 | EFO_0004531, EFO_0009270 | |
| Disease | Alveolitis, Fibrosing | 5.92e-04 | 83 | 58 | 3 | C4721507 | |
| Disease | FEV/FEC ratio | 6.16e-04 | 1228 | 58 | 9 | EFO_0004713 | |
| Disease | Pulmonary Fibrosis | 6.35e-04 | 85 | 58 | 3 | C0034069 | |
| Disease | Renal glomerular disease | 9.36e-04 | 23 | 58 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 9.36e-04 | 23 | 58 | 2 | C4521256 | |
| Disease | methionine measurement | 1.20e-03 | 26 | 58 | 2 | EFO_0009771 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.93e-03 | 125 | 58 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.93e-03 | 125 | 58 | 3 | C1879321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPGAACAFGLCCKDC | 441 | Q9UKJ8 | |
| KGPCDRCGQCRFGAL | 531 | O00468 | |
| KKYIGPCGGRDCSVC | 41 | P53420 | |
| GGKKGAVECCPNCRG | 141 | P31689 | |
| ECLGNGKTVCKCGAP | 2061 | Q96L73 | |
| GKCTCAPGFKGIDCS | 426 | Q96KG7 | |
| KACLGCMGAGPGRCK | 276 | Q96HD1 | |
| GNGTTCKAFCKDGCR | 516 | Q99435 | |
| KIGGCRAELAPFCCK | 51 | Q8IZN7 | |
| KCGCLGGCRFFGGTV | 1126 | Q2LD37 | |
| GRCDFCCDKPKFGGS | 351 | Q9UIS9 | |
| KKCDISCLTCNGPGF | 836 | Q92824 | |
| QGRCKKTCRDVFCPG | 161 | P19883 | |
| AEGKPLCSGRGDCSC | 516 | P18084 | |
| GCAKCARGCICKGGS | 41 | P47944 | |
| GKGFLECGICRCDTG | 461 | P05107 | |
| IGCGICIKKCPFGAL | 56 | P61221 | |
| GTPCKYEGRCFRKGC | 486 | Q9UKF2 | |
| SCTCLGNGKGEFKCD | 2366 | P02751 | |
| KDSCDGVECGPGKAC | 96 | O95633 | |
| GCSPGSKCDCSGIKG | 31 | P29400 | |
| AYGDCCKDCRFLPGG | 456 | Q13443 | |
| CKDCRFLPGGTLCRG | 461 | Q13443 | |
| DCGVCTNCLDKPKFG | 1166 | Q03164 | |
| TGQCPCKLGYGGKRC | 1096 | A4D0S4 | |
| KGGRCCCFSPDGKAL | 1041 | Q05BV3 | |
| KGGRCCAFSPDGKAL | 1041 | Q6ZMW3 | |
| GGKCQEGKSECSCPA | 31 | Q0D2K5 | |
| FPGGACLGKACGRKR | 771 | P15502 | |
| SDLPCSGRGKCECGK | 331 | O95965 | |
| SGRGKCECGKCTCYP | 336 | O95965 | |
| GFCECKTGTTGPKCD | 436 | Q9Y2I2 | |
| CKCPPGFLGTRCGKN | 1331 | Q4LDE5 | |
| CDCGPGFKGRRCELA | 1331 | Q8TER0 | |
| GGALLCCSCPPREKK | 176 | O15551 | |
| PSDRCVCGGCYLGKS | 141 | Q8NAA6 | |
| CPKCKFSYALARGGC | 871 | Q96EP0 | |
| GEKCCKSGCGRFCVP | 191 | Q8IUB2 | |
| CFRKCIGKPGGSLDN | 46 | Q9Y5L4 | |
| GRAGCCLGKAVRGAK | 56 | O15105 | |
| CSDFLKGYCPLGAKC | 756 | Q8IXZ2 | |
| KCGVCGKGFGDSSAR | 141 | Q96MX3 | |
| KCGICGKGFGDSSAR | 221 | Q96MX3 | |
| PYGCKQCGKGFRCAS | 366 | P17024 | |
| KPFKCGECGKAFNCG | 141 | Q8N8Y5 | |
| RGCAGGCECGDKGKC | 11 | Q9NYP9 | |
| FGCASCPKLTCGREG | 231 | Q9NV58 | |
| KGRPFPCGACGRSFK | 121 | Q9H7X3 | |
| GEKPCRCEECGKAFS | 321 | Q96JC4 | |
| GERPFSCRKCGKGFA | 421 | Q8N393 | |
| CKICGKGFDCPSSLQ | 351 | Q9H7R0 | |
| KPFGCGECGKAFSRS | 291 | Q9BRH9 | |
| KCKICGKGFDCPSSL | 366 | Q9Y2A4 | |
| CSKCGKAFRGCSGLT | 551 | Q3MIS6 | |
| KCGVCGKCFGRSRSL | 776 | Q63HK3 | |
| SGGPLTCKVCGKSCD | 1196 | Q8N1G0 | |
| KGFGCCFPCCSVDKR | 1021 | Q9UI33 | |
| KPFKCDICGKSFCGR | 286 | Q9NZL3 | |
| KGRPCCIGTKGSCEI | 596 | Q6PJF5 | |
| CDECGKGFGFRSLLC | 346 | Q96NJ3 | |
| PCICDECGRGFGFKS | 541 | Q14929 | |
| TERPFKCGECGKCFS | 656 | B7Z6K7 | |
| CGDLRAGKPACALCP | 91 | Q9BRZ2 | |
| RPFRCVDCGKGFAKG | 451 | Q6AW86 |